June 9, 2026 · Form 4 insider transaction
Coughlin Timothy bought 8,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.; 1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.